Optimizing PrEP uptake & Adherence among MSWs using a 2-stage randomization design
优化 PrEP 的吸收
基本信息
- 批准号:9565054
- 负责人:
- 金额:$ 7.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-23 至 2019-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAddressAdherenceAlcohol or Other Drugs useAnal SexBehavior TherapyBehavioralBisexualBloodCaringCase ManagementClientClinicClinical TrialsCognitiveCohort StudiesComplexCounselingCountryDataDecision MakingDoseDropsEnsureEpidemiologyEvaluationEvidence based interventionFaceFocus GroupsFutureGaysGrantHIVHIV InfectionsHIV riskHairHomelessnessHospitalsIndividualInjection of therapeutic agentInternetInterventionInterviewLifeLife ExperienceLinkManualsMeasuresMental DepressionMeta-AnalysisMethodsModalityOralParticipantPatient Self-ReportPharmaceutical PreparationsPhasePopulationPopulations at RiskPrevalencePreventive InterventionProblem SolvingProceduresProcessProfessional counselorPublishingQuestionnairesRandomizedRandomized Controlled TrialsResearchResearch InfrastructureResearch PersonnelRhode IslandRiskSamplingSiteSubgroupSurveysTenofovirTestingTimeTrainingUnemploymentUnited StatesUnited States National Institutes of HealthUniversitiesVictimizationVisitWorkantiretroviral therapybasecisgenderclinical caredesignefficacy trialemtricitabinefollow-uphigh riskinnovationmalemale sex workermenmen who have sex with menpeerpillpilot trialpre-clinicalpre-exposure prophylaxisprimary outcomeprogramspsychosocialpublic health relevancesecondary outcomesexskills trainingstandard of caretheoriestransgender womentransmission processtreatment adherencetruvadauptake
项目摘要
DESCRIPTION (provided by applicant): Background: Male sex workers (MSW), or men who exchange sex for money, drugs, or other items of value with other men, are at exceptionally high risk for HIV infection. Pre-exposure prophylaxis (PrEP, truvada) is effective for reducing HIV acquisition among HIV uninfected individuals, but its efficacy is highly dependent on uptake and excellent adherence, which can pose problems among certain groups. Providence, Rhode Island (RI) is primed to be a site for testing of a PrEP initiation and adherence intervention for MSW, as it has a sizeable market for MSW (>1,000 street and internet based MSW). Additionally, Providence is the site of the nation's first drop-in center for MSW, called Project Weber, and is the site of one of the first clinical PrEP programs in the country, led by our team at Miriam Hospital/Brown University. Overview: Informed by our abundance of formative research and programmatic work with MSWs in the US, our interdisciplinary investigator team designed the "PrEPare for Work" package that includes two components: 1) peer-led strengths-based case management (SBCM) for PrEP initiation and 2) a counseling and problem-solving PrEP adherence intervention that addresses individualized barriers to optimal use. We propose to pilot test the "PrEPare for Work" package in two phases, laying the groundwork for a future R01 efficacy trial. We will: (Phase 1) conduct an open phase evaluation of "PrEPare for Work". The intervention will be piloted with up to 10 MSW. Acceptability and feasibility data and participant exit interviews will be used to finalize all study procedures, questionnaire and intervention manual for use in the next phase; (Phase 2) conduct a pilot randomized controlled trial (RCT) of "PrEPare for Work" using a two-stage randomization design. Stage 1: 106 MSW will be equally randomized to receive either the peer-led SBCM or standard of care (i.e., referrals only) for engagement with our existing PrEP clinic. Stage 2: Those from stage 1 who initiate PrEP (n~44), regardless of stage 1 randomization condition, will then be equally randomized to either the "PrEPare for Work" adherence intervention or standard of care comparison condition. In stage 1, the primary outcome is PrEP initiation (initial prescription filled, time-to-PrEP initiation). In stage 2, the primary outcomes are PrEP adherence (% of truvada-blood levels, hair samples, self-report) and retention in PrEP care at 6 months. Major study assessment visits are: for stage 1, baseline and 1-month follow up; for stage 2, baseline, 3-, and 6- months. Innovation: Evidence-based interventions to enhance uptake and optimize adherence of PrEP among at risk populations with complex life experiences must be developed and tested. This will ensure that individuals, such as MSW, who are most in need of PrEP, can benefit from its application. The current study would be the first of its kind with respect to "packaging" PrEP for MSW. By linking MSW to our team's existing PrEP program for ongoing PrEP clinical care, we will leverage existing infrastructure-enhancing the sustainability of the "PrEPare for Work" package, if shown to be effective in an eventual R01 efficacy RCT.
描述(由申请人提供):背景:男性性工作者(MSW),或与其他男性以性换取金钱、毒品或其他有价值物品的男性,感染艾滋病毒的风险极高。暴露前预防(PrEP,Truvada)可有效减少未感染艾滋病毒的个体感染艾滋病毒,但其疗效高度依赖于吸收和良好的依从性,这可能会在某些群体中造成问题。罗得岛的普罗维登斯(RI)准备成为测试城市固体废物PrEP启动和依从性干预的地点,因为它具有相当大的城市固体废物市场(> 1,000个街道和基于互联网的城市固体废物)。此外,普罗维登斯是全国第一个城市固体废物下降中心的所在地,称为韦伯项目,也是全国第一个临床PrEP项目之一的所在地,由我们在米里亚姆医院/布朗大学的团队领导。概述:根据我们在美国与MSW进行的大量形成性研究和项目工作,我们的跨学科研究团队设计了“PrEP工作”包,其中包括两个组成部分:1)同行领导的基于优势的病例管理(SBCM),用于PrEP启动和2)咨询和解决问题的PrEP依从性干预,解决个性化障碍,以实现最佳使用。我们建议分两个阶段试行“工作前健康保障”计划,为日后的R 01成效试验奠定基础。我们将:(第一阶段)对“PrEPare for Work”进行开放阶段评估。干预措施将在多达10个城市固体废物中进行试点。可接受性和可行性数据以及参与者退出访谈将用于最终确定所有研究程序、问卷和干预手册,供下一阶段使用;(第二阶段)使用两阶段随机设计进行“PrEPare for Work”试点随机对照试验(RCT)。第1阶段:106名MSW将被平等随机分配接受同行领导的SBCM或标准治疗(即,仅转介)与我们现有的PrEP诊所合作。第二阶段:那些从第1阶段开始PrEP的人(n~44),无论第1阶段的随机化条件如何,然后将被平等地随机分配到“PrEP工作”依从性干预或护理标准比较条件。在第1阶段,主要结局是PrEP启动(初始处方填写,开始PrEP的时间)。在第2阶段,主要结果是PrEP依从性(Truvada血液水平的百分比,头发样本,自我报告)和6个月时PrEP护理的保留。主要研究评估访视包括:第1阶段,基线和1个月随访;第2阶段,基线、3个月和6个月。创新:必须制定和测试基于证据的干预措施,以提高具有复杂生活经历的风险人群对PrEP的吸收和优化坚持。这将确保最需要PrEP的个人,如MSW,可以从其应用中受益。目前的研究将是第一个关于“包装”城市固体废物的PrEP。通过将MSW与我们团队现有的PrEP计划联系起来,以进行持续的PrEP临床护理,如果在最终的R 01疗效RCT中证明有效,我们将利用现有的基础设施来增强“PrEPare for Work”包的可持续性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Katie Brooks Biello其他文献
Katie Brooks Biello的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Katie Brooks Biello', 18)}}的其他基金
Making universal, free-of-charge antiretroviral therapy work for sexual and gender minority youth in Brazil
为巴西的性少数群体和性别少数青年提供普遍、免费的抗逆转录病毒治疗
- 批准号:
10612852 - 财政年份:2021
- 资助金额:
$ 7.51万 - 项目类别:
Efficacy of a PrEP uptake & Adherence Intervention among male sex workers using a 2-stage randomization design
PrEP 摄取的功效
- 批准号:
10598594 - 财政年份:2021
- 资助金额:
$ 7.51万 - 项目类别:
Efficacy of a PrEP uptake & Adherence Intervention among male sex workers using a 2-stage randomization design
PrEP 摄取的功效
- 批准号:
10273650 - 财政年份:2021
- 资助金额:
$ 7.51万 - 项目类别:
Making universal, free-of-charge antiretroviral therapy work for sexual and gender minority youth in Brazil
为巴西的性少数群体和性别少数青年提供普遍、免费的抗逆转录病毒治疗
- 批准号:
10274560 - 财政年份:2021
- 资助金额:
$ 7.51万 - 项目类别:
Efficacy of a PrEP uptake & Adherence Intervention among male sex workers using a 2-stage randomization design
PrEP 摄取的功效
- 批准号:
10447813 - 财政年份:2021
- 资助金额:
$ 7.51万 - 项目类别:
Making universal, free-of-charge antiretroviral therapy work for sexual and gender minority youth in Brazil
为巴西的性少数群体和性别少数青年提供普遍、免费的抗逆转录病毒治疗
- 批准号:
10396669 - 财政年份:2021
- 资助金额:
$ 7.51万 - 项目类别:
Developing and Pilot Testing an Adaptive Intervention to Facilitate PrEP Uptake and Maximize PrEP Adherence among At-Risk Transgender Women
开发并试点测试适应性干预措施,以促进高危跨性别女性对 PrEP 的吸收并最大限度地提高 PrEP 的依从性
- 批准号:
10414059 - 财政年份:2020
- 资助金额:
$ 7.51万 - 项目类别:
Developing and Pilot Testing an Adaptive Intervention to Facilitate PrEP Uptake and Maximize PrEP Adherence among At-Risk Transgender Women
开发并试点测试适应性干预措施,以促进高危跨性别女性对 PrEP 的吸收并最大限度地提高 PrEP 的依从性
- 批准号:
10082543 - 财政年份:2020
- 资助金额:
$ 7.51万 - 项目类别:
Developing and Pilot Testing an Adaptive Intervention to Facilitate PrEP Uptake and Maximize PrEP Adherence among At-Risk Transgender Women
开发并试点测试适应性干预措施,以促进高危跨性别女性对 PrEP 的吸收并最大限度地提高 PrEP 的依从性
- 批准号:
10239233 - 财政年份:2020
- 资助金额:
$ 7.51万 - 项目类别:
Optimizing PrEP uptake & Adherence among MSWs using a 2-stage randomization design
优化 PrEP 的吸收
- 批准号:
9145451 - 财政年份:2016
- 资助金额:
$ 7.51万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 7.51万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 7.51万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 7.51万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 7.51万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 7.51万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 7.51万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 7.51万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 7.51万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 7.51万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 7.51万 - 项目类别: